Parkinson's Disease

In a significant development, Bayer’s (OTC:BAYRY) subsidiary BlueRock has reported initial success in treating Parkinson’s disease in humans using an experimental stem cell therapy, Reuters reports. Progress in Phase I Trial The Phase I trial involved 12 volunteers and lasted for a year...

Insulin-resistance drugs, such as those containing the compound semaglutide, could potentially aid in treating neurodegenerative disorders like Parkinson's disease, PsyPost reports. Insulin Resistance Drugs and Parkinson’s Research indicates that semaglutide, found in medications like Ozempic...